Ironwood Pharmaceuticals, Inc. - IRWD - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Ironwood Pharmaceuticals, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
IRWD	Nasdaq	8731	http://www.ironwoodpharma.com/	13.4425 -0.3875
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Ironwood Pharmaceuticals, Inc. Ironwood Pharma Plans 10.5M-Share Offering - May 20th, 2013 2:32 pm InPlay: Ironwood Pharma announces proposed public offering of 10.5 mln shares of common stock - May 20th, 2013 2:05 pm Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock - May 20th, 2013 2:05 pm IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 20th, 2013 7:13 am Ironwood Linzess may not be suitable for some patients, says Cantor - May 20th, 2013 5:11 am Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013 - May 14th, 2013 6:00 am Top Life Science Investors Of 2013 - May 9th, 2013 9:00 am Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Health Care Conference - May 7th, 2013 2:00 pm Analyst downgrades Ironwood Pharma on expenses - May 6th, 2013 11:47 am Analyst downgrades Ironwood Pharma on expenses - May 6th, 2013 11:47 am Ironwood Pharmaceuticals Enters Oversold Territory (IRWD) - May 1st, 2013 10:45 am The Compelling Science Behind Synergy - Apr 29th, 2013 3:14 am The Best- And Worst-Performing Biotech Stocks, April 19 to April 26 - Apr 27th, 2013 6:00 am 3 Horrendous Health-Care Stocks This Week - Apr 27th, 2013 5:30 am IRONWOOD PHARMACEUTICALS INC Financials - Apr 26th, 2013 11:04 am David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc., Interviews with The Wall Street Transcript: Opportunities in Hepatitis C and Genomic Technologies - Apr 26th, 2013 10:39 am 3 Stocks Underperforming Today In The Health Services Industry - Apr 25th, 2013 11:03 am Synergy On Sale: Why This Opportunity Shouldn't Be Missed - Apr 25th, 2013 9:46 am Loss Widens at Ironwood - Apr 24th, 2013 1:30 pm Nicor Gets a Thumbs Down and 4 More Analyst Downgrades To Know - Apr 24th, 2013 11:55 am View All Current Headlines >>